Enfermedades retinianas y nuevas terapias
University of Sydney
Sídney, AustraliaPublicaciones en colaboración con investigadores/as de University of Sydney (3)
2024
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
Ophthalmology, Vol. 131, Núm. 8, pp. 914-926
2018
-
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Brain, Vol. 141, Núm. 10, pp. 2895-2907
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677